Hyperprolactinaemia

E4_HYPERPRO

hyperprolactinemia: An acquired metabolic disease that has_material_basis_in the presence of abnormally-high levels of prolactin in the blood.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E22.1# Hospital discharge: ICD-9 — 2531A Cause of death: ICD-10 — E22.1# Cause of death: ICD-9 — 2531A 2 out of 7 registries used, show all original rules.	1385
4. Check minimum number of events None	1385
5. Include endpoints None	1385
6. Filter based on genotype QC (FinnGen only)	1385

Control definitions (FinnGen only)

Control exclude: E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E22
Name in latin: Hyperprolactinaemia

NAME	E4_HYPERPRO
CONTROL_EXCLUDE	E4_ENDOGLAND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E221
HD_ICD_9	2531A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E221
COD_ICD_9	2531A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hyperprolactinaemia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Hyperprolactinaemia, drug-induced

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	7858	6346	1386
Only index persons	7530	6218	1312
Unadjusted period prevalence (%)
Whole population	0.16	0.18	0.04
Only index persons	0.20	0.23	0.05
Median age at first event (years)
Whole population	35.99	33.41	47.97
Only index persons	35.83	33.35	47.61

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1385	1145	240
Unadjusted period prevalence (%)	0.34	0.39	0.11
Median age at first event (years)	36.66	33.92	49.73

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1263: Matched controls
12629

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

774.0

323.0

382

G02CB01

ATC

bromocriptine; systemic

53.3

323.0

451

130

E22.1

ICD-10 Finland

Hyperprolactinaemia

4503599627370496.0

323.0

1235

N04BC06

ATC

cabergoline; oral (dopamine agonists)

583.0

323.0

404

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

308.9

292.4

287

G02CB03

ATC

cabergoline; oral (prolactine inhibitors)

164.3

176.7

183

N91.1

ICD-10 Finland

Secondary amenorrhoea

12.7

76.9

142

125

G02CB04

ATC

quinagolide; oral

+∞

66.2

N05AX08

ATC

risperidone; systemic

6.2

65.9

192

357

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

5.2

64.0

216

478

H02AB09

ATC

hydrocortisone; systemic

16.1

63.0

104

101

Kela drug reimbursment

Anterior pituitary hypofunction

+∞

59.9

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

154.6

56.4

E23.00

ICD-10 Finland

Panhypopituitarism

+∞

50.3

G03DB01

ATC

dydrogesterone; oral

2.9

46.4

330

1352

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

+∞

46.1

2531A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Other and unspecified anterior pituitary hyperfunction[HYPERPROLACTINAEMIA]

+∞

46.1

N05AH03

ATC

olanzapine; systemic

4.6

43.6

163

395

F29

ICD-10 Finland

Unspecified nonorganic psychosis

6.0

43.6

126

228

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

431.5

42.4

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

144.7

40.0

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

9.3

39.0

N05AX12

ATC

aripiprazole; systemic

5.1

38.3

127

270

N05AH04

ATC

quetiapine; oral

2.6

36.3

312

1405

N05AB03

ATC

perphenazine; systemic, rectal

5.7

31.8

178

N05AH02

ATC

clozapine; systemic

7.7

31.3

101

H03AA01

ATC

levothyroxine sodium; systemic

2.3

31.2

359

1862

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

19.3

28.4

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.0

28.4

530

3358

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

+∞

28.2

E22.0

ICD-10 Finland

Acromegaly and pituitary gigantism

+∞

27.2

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

143.1

26.7

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

+∞

26.1

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

74.3

25.9

E23.05

ICD-10 Finland

Lack of TSH

+∞

25.1

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

4.6

25.1

203

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

+∞

24.0

N04BC01

ATC

bromocriptine; oral

244.4

23.7

N05AA02

ATC

levomepromazine; systemic

4.7

23.7

187

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

6.2

22.8

104

N05BA06

ATC

lorazepam; systemic, sublingual

4.4

22.5

206

N06AB04

ATC

citalopram; systemic

2.1

22.2

306

1681

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

7.4

21.4

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.6

21.3

290

XLA10

NOMESCO Finland

3.3

21.0

113

370

P72

ICPC

Schizophrenia

6.5

21.0

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.5

20.4

178

785

N03AG01

ATC

valproic acid; systemic, rectal

3.2

20.4

111

367

N97.0

ICD-10 Finland

Female infertility associated with anovulation

5.0

19.7

133

N97.9

ICD-10 Finland

Female infertility, unspecified

2.7

19.7

144

574

N06AX16

ATC

venlafaxine; oral

2.2

19.7

235

1209

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.2

19.1

223

1134

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.6

19.1

104

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

11.6

19.0

N04AA02

ATC

biperiden; systemic

5.9

18.9

N05AN01

ATC

lithium; oral

5.1

18.6

120

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

8.0

18.1

N03AX09

ATC

lamotrigine; oral

3.1

18.0

103

352

XCK00

NOMESCO Finland

Perimetry

3.3

17.9

297

C07AA05

ATC

propranolol; systemic

1.9

17.0

285

1668

E22.9

ICD-10 Finland

Hyperfunction of pituitary gland, unspecified

+∞

16.7

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

16.0

271

1589

N05AF03

ATC

chlorprothixene; systemic

4.5

16.0

132

N05BA04

ATC

oxazepam; oral

1.8

15.9

316

1960

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

8.5

15.8

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.5

15.7

230

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.5

15.7

130

2542

FHL

Transasal hypophysectomy

+∞

15.7

102

Kela drug reimbursment

Diabetes insipidus

+∞

15.7

N06AB03

ATC

fluoxetine; oral

2.1

15.2

179

907

E23.6

ICD-10 Finland

Other disorders of pituitary gland

+∞

14.6

D352, E221

ICD-10 Finland

+∞

14.6

N05CD07

ATC

temazepam; oral

2.5

14.3

117

498

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

14.1

201

1102

E21.0

ICD-10 Finland

Primary hyperparathyroidism

40.5

13.2

N06AX11

ATC

mirtazapine; oral

1.6

13.1

382

2630

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.7

13.0

155

N91.4

ICD-10 Finland

Secondary oligomenorrhoea

9.5

13.0

N05AE03

ATC

sertindole; oral

15.6

12.6

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.3

12.6

110

188

Kela drug reimbursment

Psychosis requiring demanding treatment

6.0

12.3

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

12.2

113

510

R51.80

ICD-10 Finland

Headache

1.8

12.1

215

1272

N05AF05

ATC

zuclopenthixol; systemic

7.6

11.9

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.9

11.9

126

P29

ICPC

Psychological sympt/compl other

2.4

11.9

106

470

N05AA01

ATC

chlorpromazine; systemic, rectal

5.6

11.7

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

19.1

11.6

N05CF01

ATC

zopiclone; oral

1.6

11.5

323

2185

AA1AD

NOMESCO Finland

CT of head and brain

1.8

11.4

202

1191

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

7.0

11.4

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

7.0

11.4

N91.2

ICD-10 Finland

Amenorrhoea, unspecified

8.3

10.8

L17

ICPC

Foot/toe symptom/complaint

1.7

10.8

267

1744

X05

ICPC

Menstruation absent/scanty

5.3

10.8

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

10.8

392

2829

N05AE04

ATC

ziprasidone; systemic

6.8

10.7

R53

ICD-10 Finland

Malaise and fatigue

1.7

10.7

242

1539

N05AD01

ATC

haloperidol; systemic

4.1

10.5

101

E22.88

ICD-10 Finland

Other hyperfunction of pituitary gland

+∞

10.4

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.3

10.3

154

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

10.2

287

1937

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.7

10.0

N03AE01

ATC

clonazepam; systemic

2.6

10.0

299

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

7.3

10.0

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

9.2

9.5

N05AC02

ATC

thioridazine; oral

3.8

9.5

101

H01CB02

ATC

octreotide; parenteral

30.3

9.4

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.2

9.4

25320

ICD-8 Finland

Diseases of pituitary gland, Chromophobe adenoma, pituitary

+∞

9.4

E23.03

ICD-10 Finland

Lack of ACTH

+∞

9.4

UJF32

NOMESCO Finland

Coloscopy

1.7

9.4

231

1499

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.7

9.3

108

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

5.8

9.2

N06AX21

ATC

duloxetine; oral

1.9

9.2

141

790

R42

ICD-10 Finland

Dizziness and giddiness

1.7

9.2

204

1288

N05AF01

ATC

flupentixol; systemic

4.8

9.2

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

9.1

366

2682

N05BA01

ATC

diazepam; systemic, rectal

1.9

9.1

140

786

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

7.1

9.0

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

10.1

9.0

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.0

8.9

177

N06AB05

ATC

paroxetine; oral

2.2

8.9

398

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.8

8.9

N05AX13

ATC

paliperidone; systemic

8.0

8.9

C03CA01

ATC

furosemide; systemic

1.8

8.7

164

982

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

50.3

8.7

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

6.2

8.6

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

8.6

101

511

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

8.6

172

1052

AA400

NOMESCO Finland

Electroconvulsive therapy

5.8

8.6

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.0

8.6

113

597

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.8

8.6

N06AB06

ATC

sertraline; oral

1.8

8.5

153

905

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.4

8.5

122

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.5

8.5

261

K59.0

ICD-10 Finland

Constipation

2.7

8.5

218

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

8.4

481

3775

E23.2

ICD-10 Finland

Diabetes insipidus

90.6

8.4

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

8.4

267

1849

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.3

8.3

F28

ICD-10 Finland

Other nonorganic psychotic disorders

10.8

8.3

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

8.3

142

827

X21

ICPC

Breast sympt/compl female other

3.2

8.2

131

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.8

8.2

193

R11

ICD-10 Finland

Nausea and vomiting

2.1

8.2

473

N06AG02

ATC

moclobemide; oral

2.6

8.2

218

F22.0

ICD-10 Finland

Delusional disorder

4.7

8.1

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

8.1

106

561

N05AL01

ATC

sulpiride; systemic

5.1

8.0

F61.0

ICD-10 Finland

Mixed personality disorders

3.5

7.9

102

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.1

7.9

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

6.4

7.7

P28

ICPC

Limited function/disability (P)

6.4

7.7

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

7.5

7.7

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

6.7

7.6

A02BC02

ATC

pantoprazole; systemic

1.4

7.6

688

5839

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

7.6

493

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

10.1

7.5

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.3

7.5

112

S18

ICPC

Laceration/cut

1.4

7.5

379

2891

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.2

7.5

118

N03AX16

ATC

pregabalin; oral

1.6

7.5

232

1593

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

7.4

230

1579

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

7.4

134

793

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

7.4

266

1890

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

7.3

229

1576

106

Kela drug reimbursment

Hypoparathyroidism

+∞

7.3

E23

ICD-10 Finland

Hypofunction and other disorders of pituitary gland

+∞

7.3

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

+∞

7.3

X78

ICD-10 Finland

Intentional self-harm by sharp object

5.8

7.2

G03GA01

ATC

chorionic gonadotrophin; parenteral

2.1

7.2

374

D35.31

ICD-10 Finland

Cyst in Rathke's pocket

20.1

7.1

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

7.1

115

658

R06.0

ICD-10 Finland

Dyspnoea

1.6

7.1

221

1518

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

7.1

436

3446

IEY19

NOMESCO Finland

Psychiatric health counselling and guidance

12.1

7.1

F21

ICD-10 Finland

Schizotypal disorder

6.1

7.1

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

2.3

7.0

278

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

10.1

7.0

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

10.1

7.0

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

7.0

169

X07

ICPC

Menstruation irregular/frequent

3.4

6.9

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

6.9

130

779

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.0

6.9

126

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

6.9

138

845

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

40.3

6.8

XF404

NOMESCO Finland

Ambulatory ECG

2.1

6.7

378

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

6.7

143

891

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

2.9

6.7

139

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.8

6.7

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

6.7

182

1211

N06AX18

ATC

reboxetine; oral

5.2

6.6

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

5.5

6.6

N91.5

ICD-10 Finland

Oligomenorrhoea, unspecified

5.9

6.6

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

6.6

127

767

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

10.1

6.5

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

6.9

6.5

R07.3

ICD-10 Finland

Other chest pain

1.9

6.5

465

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

5.1

6.5

P01

ICPC

Feeling anxious/nervous/tense

1.6

6.5

173

1144

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

6.4

184

1235

E66.8

ICD-10 Finland

Other obesity

2.0

6.4

387

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

6.3

353

G47.3

ICD-10 Finland

Sleep apnoea

1.6

6.3

186

1259

N05BE01

ATC

buspirone; oral

2.8

6.3

133

O92.6

ICD-10 Finland

Galactorrhoea

11.1

6.3

E29.1

ICD-10 Finland

Testicular hypofunction

9.3

6.3

E21.2

ICD-10 Finland

Other hyperparathyroidism

+∞

6.3

2370A

ICD-9 Finland

Neoplasm of uncertain behaviour of endocrine glands and nervous system, Pituitary gland and craniopharyngeal duct

+∞

6.3

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

7.1

6.2

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.1

6.2

G03DA04

ATC

progesterone; systemic, rectal, vaginal

2.3

6.2

254

P99

ICPC

Psychological disorders other

2.6

6.2

176

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.3

6.2

P73

ICPC

Affective psychosis

6.3

6.2

U02

ICPC

Urinary frequency/urgency

1.6

6.2

144

919

M79.6

ICD-10 Finland

Pain in limb

1.4

6.1

383

3018

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.9

6.1

122

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

6.1

288

2156

N03AX12

ATC

gabapentin; oral

1.6

6.1

154

1007

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3036481) Cortisol [Moles/volume] in Serum or Plasma

547

999

8.40

313.39

3.6

1.8

nmol/l

367.8

378.1

0.62

529

926

(43055514) Macroprolactin [Presence] in Serum or Plasma

301

116.26

307.65

2.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

667

700

17.45

307.65

5.8

1.3

mu/l

706.8

294.0

9.41

641

625

(3009214) Lutropin [Units/volume] in Serum or Plasma

320

386

10.48

256.03

1.7

1.2

u/l

8.0

11.4

3.42

260

318

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

239

208

13.68

238.70

4.9

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

251

442

6.71

141.15

4.7

1.8

nmol/l

9.4

11.7

3.12

229

395

(3035637) Corticotropin [Mass/volume] in Plasma

120

13.59

124.53

1.4

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

180

324

6.24

97.78

1.5

1.3

nmol/l

0.3

0.5

2.12

139

268

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

40.31

94.98

1.5

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

102

120

9.10

80.80

3.0

1.4

pmol/l

151.8

186.8

1.20

110

(3023323) Follitropin [Units/volume] in Serum or Plasma

304

1098

3.27

65.30

1.6

1.3

iu/l

17.1

27.4

7.04

251

952

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1204

9539

3.01

43.94

6.6

4.1

pmol/l

14.5

14.3

1.09

1160

8931

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

116

301

4.11

40.23

1.8

1.4

u/l

14.4

25.8

4.66

104

251

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

632

3951

2.10

39.08

6.9

5.0

mmol/l

1.2

0.81

594

3608

(3018418) pH of Serum or Plasma

460

2613

2.14

35.96

4.7

3.2

7.4

0.47

476

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

679

4462

2.02

35.59

7.9

5.6

mmol/l

1.2

1.13

578

3794

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1277

10973

3.10

30.20

7.2

4.7

mu/l

1.7

1.9

0.91

1233

10376

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

8.33

29.58

1.4

nmol/l

1.4

1.7

0.16

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

196

841

2.55

29.01

2.8

3.3

pmol/l

4.4

4.6

2.53

181

761

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

10.93

27.84

1.4

1.1

—

(3001556) Androgen free Index in Serum or Plasma

16.69

27.21

1.5

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

995

8106

1.81

21.12

7.6

6.7

u/l

74.6

73.7

0.34

948

7659

(3019550) Sodium [Moles/volume] in Serum or Plasma

1275

11380

2.52

19.94

16.9

10.7

mmol/l

139.8

139.6

2.46

1250

11085

(42870588) Differential panel, method unspecified - Blood

512

3517

1.72

19.77

6.4

5.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1275

11423

2.46

19.00

17.0

10.7

mmol/l

3.9

0.03

1249

11100

(3013707) Erythrocyte sedimentation rate by Westergren method

1002

8293

1.75

18.82

4.1

3.7

mm/h

11.0

9.9

1.93

943

7772

(3024561) Albumin [Mass/volume] in Serum or Plasma

549

3914

1.67

18.02

4.7

4.4

g/l

36.3

36.7

0.95

505

3671

(3013826) Glucose [Moles/volume] in Serum or Plasma

750

5789

1.64

17.97

5.7

4.1

mmol/l

6.3

6.4

1.51

696

5286

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

618

4547

1.65

17.90

2.8

2.1

nmol/l

74.2

74.7

0.19

574

4224

(3015377) Calcium [Moles/volume] in Serum or Plasma

472

3239

1.69

17.89

3.2

3.1

mmol/l

2.3

0.19

425

2918

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

108

4.27

17.27

9.0

12.0

mmol/l

0.6

0.47

(3019309) Folate [Moles/volume] in Red Blood Cells

241

1388

1.89

16.45

1.9

1.6

nmol/l

1164.7

1177.6

0.07

198

1091

(3003458) Phosphate [Moles/volume] in Serum or Plasma

187

993

2.02

16.18

6.7

5.4

mmol/l

1.0

0.50

174

934

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

119

541

2.31

15.25

4.4

3.1

ng/l

97.2

71.4

0.86

102

490

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1122

9838

1.74

14.38

5.2

4.4

mmol/mol

37.6

38.1

1.00

1070

9315

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

506

3717

1.57

13.72

2.0

1.7

pmol/l

102.4

98.3

1.06

267

1999

(3008295) Osmolality of Serum or Plasma

4.25

13.47

2.2

1.4

mosm/kgh2o

290.2

282.2

1.60

(3001122) Ferritin [Mass/volume] in Serum or Plasma

750

6035

1.53

13.27

3.1

2.8

ug/l

90.2

80.5

0.36

701

5714

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1198

10798

1.81

12.76

4.6

3.6

mmol/l

5.7

0.25

1133

10123

(3021589) Normoblasts [#/volume] in Blood

642

5056

1.50

12.20

10.6

7.6

e9/l

0.0

0.59

547

4140

(3013650) Neutrophils [#/volume] in Blood by Automated count

789

6499

1.50

11.92

13.0

8.5

e9/l

4.0

3.9

0.57

706

5721

(3021960) Folate [Moles/volume] in Serum or Plasma

301

2013

1.63

11.83

1.5

1.4

nmol/l

19.5

20.7

0.85

263

1788

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

182

1062

1.82

11.72

2.5

2.1

u/l

5698.1

6153.4

0.08

423

(3018010) Neutrophils/100 leukocytes in Blood

682

5480

1.48

11.49

6.7

5.4

56.2

56.6

0.46

648

5171

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

365

2586

1.56

11.17

2.4

2.0

mg/l

2.6

2.7

0.50

308

2249

(3002030) Lymphocytes/100 leukocytes in Blood

686

5538

1.47

11.17

7.1

5.6

29.6

29.3

0.34

646

5212

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

377

2694

1.55

11.09

3.5

2.0

u/l

162.2

165.7

0.04

358

2559

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

432

3189

1.52

10.90

3.0

2.4

u/l

53.4

54.8

0.30

398

2970

(3022096) Basophils/100 leukocytes in Blood

637

5089

1.47

10.82

7.0

5.7

0.7

0.53

601

4769

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

128

689

1.95

10.56

3.8

2.7

mmol/l

1.2

0.32

113

586

(3004789) Transferrin [Mass/volume] in Serum or Plasma

211

1323

1.70

10.54

2.6

2.1

g/l

2.5

2.4

0.13

186

1231

(3006504) Eosinophils/100 leukocytes in Blood

656

5289

1.46

10.52

7.1

5.6

2.8

2.7

0.56

617

4945

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

959

8319

1.50

10.52

3.6

2.8

u/l

41.4

37.0

0.88

924

7975

(3013115) Eosinophils [#/volume] in Blood

717

5886

1.45

10.42

7.4

5.9

e9/l

0.2

0.25

634

5277

(3019069) Monocytes/100 leukocytes in Blood

659

5329

1.45

10.34

7.4

5.9

8.1

8.0

0.43

625

5030

(3019198) Lymphocytes [#/volume] in Blood

711

5872

1.43

9.74

7.0

5.6

e9/l

2.0

0.00

633

5289

(3006315) Basophils [#/volume] in Blood

691

5679

1.43

9.71

6.9

5.7

e9/l

0.0

0.19

604

4986

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1179

10762

1.64

9.71

12.9

8.9

ml/min/173m2

89.5

90.7

1.20

1029

8745

(3012095) Magnesium [Moles/volume] in Serum or Plasma

214

1379

1.65

9.60

3.4

3.3

mmol/l

0.8

0.08

200

1297

(3001604) Monocytes [#/volume] in Blood

685

5658

1.42

9.16

7.0

5.6

e9/l

0.5

0.53

600

4977

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

490

3820

1.44

9.01

3.5

3.1

u/l

27.3

28.7

0.70

464

3657

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

234

1573

1.59

8.80

2.6

2.5

mmol/l

2.4

1.70

196

1369

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

274

1914

1.54

8.69

1.5

1.6

pmol/l

33476862.3

46663117.2

0.14

233

1678

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

366

2721

1.47

8.57

1.6

mmol/l

1.5

1.4

2.11

319

2355

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.20

8.41

2.5

2.3

umol/l

15.6

16.7

0.13

(1001926) Buprenorphine [Presence] in Urine by Screen method

105

577

1.89

8.16

3.0

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1252

11711

1.72

8.12

15.1

10.6

mg/l

18.5

20.1

0.90

979

8994

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

184

1197

1.62

7.89

2.8

2.2

22.2

24.2

1.18

153

1038

(3023511) Choriogonadotropin [Units/volume] in Urine

105

585

1.86

7.82

1.5

1.3

—

(3042517) Benzodiazepines panel - Urine

8.39

7.58

2.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

216

1475

1.55

7.52

2.8

2.1

umol/l

13.9

14.4

0.52

196

1364

(40758558) Short blood count panel - Blood

367

2788

1.43

7.52

8.7

6.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

102

571

1.85

7.49

2.9

2.7

g/l

66.5

67.6

0.82

535

(3026782) Osmolality of Urine

255

1807

1.50

7.48

3.1

2.4

mosm/kgh2o

523.8

541.8

0.57

221

1540

(3002582) Erythrocytes [#/volume] in Urine

375

2863

1.42

7.47

3.6

2.7

e6/l

69.1

114.8

0.48

291

2132

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

394

3040

1.41

7.38

1.4

1.3

u/ml

1.1

1.5

0.65

100

856

(4198724)

3.71

7.20

2.1

1.9

—

(3027008) Opiates [Presence] in Urine

123

740

1.73

7.10

2.8

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

114

673

1.76

7.04

8.8

7.6

mmol/l

1.1

1.3

1.75

114

645

(3028300) Cannabinoids [Presence] in Urine

123

742

1.72

7.04

2.9

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

122

737

1.72

6.95

2.9

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

327

2.07

6.92

3.8

2.3

—

(3011288) Drugs identified in Urine by Screen method

512

1.85

6.90

4.3

2.6

—

(3044889) 12 lead EKG panel

821

7181

1.35

6.82

3.8

2.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1206

11267

1.54

6.79

4.4

3.6

mmol/l

4.8

0.69

1149

10723

(3000991) Gas panel - Venous blood

103

597

1.78

6.77

11.2

9.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1298

12351

1.81

6.77

11.1

8.6

u/l

26.2

24.9

1.98

1258

12002

(40768797) Stomach Pathology biopsy report

204

1407

1.53

6.77

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

340

2591

1.41

6.75

3.6

2.6

e6/l

0.2

0.4

2.88

254

1885

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1216

11387

1.56

6.70

4.7

3.9

mmol/l

2.9

0.06

1154

10755

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

7.19

6.70

1.7

1.1

nmol/l

6.6

4.0

—

(3007461) Platelets [#/volume] in Blood

1366

13257

3.22

6.67

25.1

15.7

e9/l

266.0

263.8

0.62

1347

13003

(3004588) Protein electrophoresis panel - Serum or Plasma

452

1.89

6.66

2.8

2.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1163

10795

1.48

6.64

3.9

3.3

mmol/l

1.3

1.2

3.48

1100

10217

(3009508) Creatinine [Moles/volume] in Urine

351

2698

1.40

6.62

3.5

3.2

mmol/l

8.2

7.9

0.53

300

2336

(36304419) Bacteria [Presence] in Urine

338

2583

1.41

6.59

3.5

2.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

130

811

1.67

6.57

8.9

kpa

12.7

13.2

0.58

122

774

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

130

811

1.67

6.57

9.0

kpa

5.2

5.1

0.97

123

773

(3003396) Base excess in Arterial blood by calculation

129

804

1.67

6.55

9.0

mmol/l

1.5

1.0

0.82

106

615

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

249

1804

1.46

6.48

3.4

2.8

ng/l

658.3

759.4

0.39

206

1492

(3024731) MCV [Entitic volume]

1366

13268

3.15

6.44

25.0

15.6

89.9

90.3

2.43

1358

13143

(3035941) MCH [Entitic mass]

1366

13270

3.14

6.40

24.9

15.6

29.9

30.1

4.08

1358

13143

(3026361) Erythrocytes [#/volume] in Blood

1366

13272

3.13

6.36

25.0

15.6

e12/l

4.5

0.27

1347

12998

(3013512) EKG study

320

2438

1.41

6.32

3.3

2.9

—

(3016879) Cocaine [Presence] in Urine

112

679

1.71

6.31

2.9

1.9

—

(3010813) Leukocytes [#/volume] in Blood

1366

13275

3.11

6.29

25.1

15.7

e9/l

6.7

0.37

1347

12990

(3007164) IgA [Mass/volume] in Serum or Plasma

337

2594

1.40

6.26

1.4

g/l

2.2

0.01

196

1682

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

224

1601

1.48

6.24

3.4

3.0

ng/l

735.9

353.2

0.35

134

931

(3032080) INR in Blood by Coagulation assay

413

3289

1.36

6.22

7.0

5.7

inr

1.1

0.29

144

1068

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.69

6.21

2.0

3.6

umol/l

83.7

162.6

1.02

(3027944) Amphetamines [Presence] in Urine

118

729

1.68

6.20

2.7

1.8

—

(3026008) Bacteria identified in Urine by Culture

382

3006

1.37

6.20

3.3

2.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

1366

13280

3.09

6.19

25.2

15.7

g/l

134.2

134.8

1.04

1358

13151

(40761536) Microorganisms panel - Urine sediment

148

974

1.58

6.04

4.0

3.4

—

(3023520) Reticulocytes [#/volume] in Blood

543

1.76

5.99

2.4

2.7

e9/l

72.7

73.5

0.08

389

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

612

5196

1.32

5.90

6.1

5.6

umol/l

9.8

10.1

0.37

571

4917

(40761511) CBC panel - Blood by Automated count

1302

12456

1.76

5.88

15.1

9.7

—

(3016018) Differential panel - Cerebral spinal fluid

107

2.75

5.88

1.0

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1196

11228

1.48

5.80

4.3

3.6

mmol/l

1.5

6.49

1138

10637

(40768443) Skin Pathology biopsy report

403

1.86

5.66

1.2

—

(3002032) Base excess in Venous blood by calculation

109

676

1.66

5.66

4.6

3.4

mmol/l

2.0

1.8

0.20

542

(3027945) Reticulocytes/100 erythrocytes in Blood

124

795

1.61

5.65

2.4

2.6

1.8

0.13

104

717

(3010421) pH of Blood

199

2.20

5.42

5.2

2.7

7.4

1.31

164

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

456

1.78

5.32

3.2

3.3

kpa

5.1

0.19

429

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

11.31

5.29

1.4

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

199

1437

1.45

5.23

3.0

2.4

e6/l

4.4

3.7

0.34

110

732

(3009343) pH of Capillary blood

451

1.77

5.22

3.2

3.3

7.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

5.21

2.0

0.0

nmol/l

341.2

—

(3000850) Epithelial cells [#/volume] in Urine

259

1962

1.39

5.21

3.1

2.3

e6/l

7.0

8.3

0.75

229

1712

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

438

1.78

5.15

3.2

3.3

mmol/l

1.3

1.7

0.46

322

(36660697) Celiac disease serology panel - Serum

153

1056

1.50

5.05

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

233

1746

1.40

4.98

1.8

1.6

—

(3019060) Gas panel - Arterial blood

444

1.75

4.93

4.5

6.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

133

896

1.54

4.91

2.3

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

106

2.58

4.90

1.1

1.2

nmol/l

—

(3023410) Appearance of Cerebral spinal fluid

118

2.49

4.89

1.0

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

379

1.81

4.84

10.6

13.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

131

884

1.53

4.81

3.3

2.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

11.49

4.78

1.0

1.3

ng/l

86.4

127.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

207

1530

1.41

4.78

2.9

2.3

e6/l

1.0

0.9

0.21

120

816

(3048689) Calprotectin [Mass/mass] in Stool

223

1670

1.40

4.78

1.8

2.4

ug/g

82.9

97.5

0.57

166

1319

(1616796) Gas panel - Central venous blood

157

2.26

4.78

5.0

2.5

—

(3023368) Bacteria identified in Blood by Culture

278

2162

1.36

4.73

4.9

3.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

134

914

1.52

4.68

2.3

1.7

—

(3012501) Base excess in Blood by calculation

165

2.21

4.68

5.4

2.6

mmol/l

2.4

2.3

0.07

106

(3033658) Prothrombin time (PT) actual/Normal

319

2537

1.33

4.67

4.0

3.4

98.2

96.7

0.55

313

2458

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

188

1372

1.43

4.66

2.4

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

826

7433

1.28

4.62

5.4

3.7

e6/l

45.0

912.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

399

3280

1.30

4.61

4.6

2.7

ng/l

30.5

29.8

0.03

202

1626

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

356

1.81

4.59

1.6

2.1

iu/l

1.8

4.9

6.56

143

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.43

4.56

1.1

—

(40768804) Tissue Pathology biopsy report

557

4795

1.27

4.44

1.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

866

7863

1.27

4.38

5.1

3.9

—

(3018095) Leukocytes [#/volume] in Urine

430

3590

1.29

4.38

4.4

3.1

e6/l

60.7

76.5

0.26

310

2337

(3017181) Myelocytes/100 leukocytes in Blood

123

837

1.52

4.36

4.9

4.1

1.1

0.03

206

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

218

1654

1.38

4.31

1.9

1.7

1.4

0.22

202

1499

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

620

1.59

4.29

1.7

—

(3000494) Fungus identified in Specimen by Culture

173

1263

1.42

4.28

1.7

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

248

1.93

4.24

2.9

3.3

mg/l

1.6

1.3

1.29

231

(3005719) IgG [Mass/volume] in Serum or Plasma

121

826

1.51

4.23

3.2

2.5

g/l

10.4

10.5

0.08

104

758

(3007566) Smooth muscle Ab [Titer] in Serum

299

1.84

4.22

1.1

1.2

titre

82.0

87.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

117

794

1.52

4.20

5.0

4.2

0.1

1.01

184

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

427

1.70

4.20

2.0

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

242

1.93

4.19

1.2

1.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

121

2.34

4.19

1.2

nmol/l

0.5

0.06

113

(3052851) Hemolysis interference index of Serum or Plasma

265

1.88

4.12

2.3

2.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

148

2.19

4.10

1.6

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

259

1.88

4.07

1.1

1.4

e6/l

288.0

12.3

0.48

204

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

259

1.88

4.07

1.2

1.5

e6/l

1569.1

1277.8

0.06

213

(3035350) Ketones [Presence] in Urine by Test strip

643

5672

1.25

4.04

3.9

3.1

estimate

0.0

0.50

135

1061

(3003327) Ova and parasites identified in Stool by Light microscopy

456

1.66

4.01

1.6

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

166

1225

1.40

3.88

2.2

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

643

5693

1.24

3.84

5.5

4.3

estimate

0.0

0.72

140

1078

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

509

1.61

3.83

2.9

2.7

ng/l

115.6

119.3

0.04

453

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

157

1150

1.41

3.83

1.3

1.2

iu/ml

124.0

145.7

0.29

450

(3042936) Bacteria identified in Isolate by Culture

178

1333

1.38

3.81

2.4

1.9

—

(3019225) pH of Specimen

122

855

1.47

3.77

4.9

3.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.02

3.70

1.1

114.1

93.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

153

1125

1.40

3.65

4.1

3.5

31.5

32.1

0.26

123

827

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.13

3.65

1.3

2.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

110

2.30

3.63

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

1083

10197

1.28

3.61

20.3

12.7

13.5

0.40

1069

9999

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

115

806

1.47

3.56

2.1

2.2

g/l

0.2

0.11

103

760

(3012516) Albumin [Mass/volume] in Urine

280

2267

1.29

3.53

3.4

3.3

mg/l

526.3

377.4

0.17

169

1449

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

2.63

3.48

3.7

2.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

244

1.83

3.47

1.7

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

159

2.04

3.46

3.2

2.1

—

(3009261) Glucose [Presence] in Urine by Test strip

645

5758

1.22

3.44

4.0

3.2

estimate

0.0

1.06

135

1056

(3000330) Specific gravity of Urine by Test strip

446

1.60

3.36

2.9

2.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

175

1.97

3.35

1.3

1.7

g/l

0.7

0.8

0.21

131

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

168

1276

1.36

3.31

4.8

4.2

ug/l

1.5

2.1

1.74

156

1156

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

529

1.54

3.29

1.6

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

363

1.65

3.26

4.8

3.4

mmol/l

24.5

24.1

0.49

330

(3025159) Blasts/100 leukocytes in Blood

107

755

1.45

3.22

5.2

4.2

0.0

1.2

0.92

155

(3022145) Colonoscopy Study observation

151

1135

1.37

3.18

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

388

3305

1.24

3.18

3.3

2.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

4.52

3.11

2.0

1.9

ug/l

49.8

61.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

300

1.69

3.06

1.8

2.2

mg/l

10.2

10.6

0.15

283

(3022313) Gas panel - Capillary blood

324

1.66

3.02

3.4

3.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.76

2.99

1.1

u/ml

0.1

2.5

—

(40767503) Oxygen content in Capillary blood by calculation

143

1.98

2.86

3.0

2.0

18.6

16.9

0.66

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

186

1.85

2.85

3.0

3.9

u/ml

0.4

0.09

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

573

1.48

2.82

7.8

2.2

ug/l

5.5

6.6

0.21

519

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

150

1149

1.34

2.82

2.5

umol/l

7.7

6.7

0.25

118

967

(3000570) Elastase.pancreatic [Mass/mass] in Stool

285

1.67

2.79

1.4

ug/g

252.6

305.7

1.03

148

(3002179) Metamyelocytes/100 leukocytes in Blood

106

769

1.41

2.78

5.2

4.0

0.4

0.6

0.79

153

(4010399)

685

1.43

2.76

1.6

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

437

1.54

2.74

7.4

8.0

mmol/l

25.5

24.4

1.60

406

(4306422)

204

1.79

2.71

1.1

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

285

2385

1.25

2.71

4.0

mg/mmol

5.9

9.7

1.31

176

1523

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

288

1.65

2.69

3.5

3.7

mmol/l

24.8

24.9

0.06

274

(3028192) IgG subclass 2 [Mass/volume] in Serum

113

2.05

2.62

1.3

1.2

g/l

2.5

2.9

1.23

(3024139) IgG subclass 3 [Mass/volume] in Serum

113

2.05

2.62

1.3

1.2

g/l

0.3

0.4

0.47

(3027135) IgG subclass 1 [Mass/volume] in Serum

113

2.05

2.62

1.3

1.2

g/l

6.2

6.7

0.39

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

291

1.64

2.59

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

108

2.05

2.52

1.3

1.6

—

(3021901) Oxygen saturation in Capillary blood

115

2.02

2.51

3.0

2.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

255

1.67

2.51

3.3

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

255

1.67

2.51

3.3

1.7

g/l

7.2

7.5

0.56

203

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

255

1.67

2.51

3.3

1.7

g/l

3.7

3.9

0.27

187

(3021879) Hepatitis B virus core Ab [Presence] in Serum

145

1127

1.32

2.48

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

2.21

2.48

11.6

5.4

mmol/l

9.7

7.0

—

(4062490)

116

2.00

2.46

1.3

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

241

1.68

2.46

3.4

1.7

g/l

3.0

3.1

0.58

193

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

115

865

1.36

2.45

2.4

2.3

au/ml

39.9

20.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

181

1.79

2.45

3.1

2.5

mmol/l

24.6

24.9

0.22

164

(3049717) Cytology report of Urine Cyto stain

219

1.71

2.43

1.9

2.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

204

1.73

2.42

1.7

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.18

2.41

1.1

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.18

2.41

7.0

3.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

213

1.71

2.37

1.5

1.3

u/ml

4.4

4.3

0.01

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.27

2.37

2.2

1.8

—

(3030313) Adrenal Ab [Titer] in Serum

6.27

2.37

1.0

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

310

2653

1.22

2.37

1.8

1.7

mg/l

0.9

0.08

234

1979

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

284

2409

1.23

2.37

2.3

2.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.27

2.34

1.6

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

214

1.70

2.34

2.6

2.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

147

1.85

2.34

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.06

2.32

1.4

1.9

—

(3004809) Band form neutrophils/100 leukocytes in Blood

119

1.95

2.31

5.2

2.9

1.4

1.5

0.08

(3014051) Protein [Presence] in Urine by Test strip

246

1.64

2.30

1.8

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

208

1.70

2.28

1.2

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

642

1.40

2.28

1.6

1.8

g/l

1.5

1.4

0.08

591

(3026493) Urate [Moles/volume] in Serum or Plasma

296

2533

1.21

2.26

2.2

umol/l

323.5

4200.7

6.38

257

2222

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

232

1.66

2.25

3.5

1.7

g/l

9.7

10.3

0.38

206

(3036489) Thrombin time

425

1.48

2.24

2.1

2.0

20.7

20.8

0.03

360

(3016650) Hepatitis A virus Ab [Presence] in Serum

217

1.68

2.23

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

313

2698

1.21

2.22

2.4

2.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

5.57

2.21

1.2

3.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.42

2.20

2.4

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

427

1.47

2.19

2.3

2.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

273

1.59

2.19

1.3

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

2.25

2.18

2.9

2.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

478

1.44

2.17

1.8

2.2

u/l

41.1

39.8

0.23

446

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

108

1.96

2.16

1.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

498

4481

1.17

2.15

4.0

3.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

174

1.74

2.14

1.1

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

174

1.74

2.14

1.1

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

110

843

1.33

2.11

4.7

4.5

u/l

229.3

250.4

0.55

103

799

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

122

951

1.31

2.08

2.9

2.3

u/l

30.1

35.9

1.00

103

801

(3006653) Thiamine [Moles/volume] in Blood

2.51

2.01

1.1

1.5

nmol/l

131.3

137.2

0.15

(3020891) Body temperature

273

1.56

1.96

5.4

4.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

396

3520

1.18

1.96

2.1

2.0

—

(3014271) Vancomycin [Susceptibility]

3.34

1.96

2.9

2.1

—

(3011412) CD3 cells [#/volume] in Blood

1.95

3.1

2.8

e9/l

1.4

1.2

—

(4268621)

149

1.76

1.95

2.8

2.3

—

(3003694) ABO and Rh group [Type] in Blood

334

3784

0.85

1.94

1.6

1.7

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.56

1.94

1.2

1.6

nmol/l

44.1

22.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.76

1.93

5.5

7.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

142

1.77

1.93

1.4

—

(3002256) Pathology report gross observation

171

1405

1.25

1.93

1.2

—

(3000012) Reticulocyte production index

2.74

1.93

1.1

1.8

—

(3024471) HLA-A [Type]

2.74

1.93

1.0

—

(3024932) HLA-DR beta [Type]

2.74

1.93

1.1

1.2

—

(3025941) Bacteria identified in Stool by Culture

743

1.33

1.89

1.3

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

205

1.62

1.87

9.6

6.2

iu/ml

384.6

329.7

—

(3042733) HLA Ab [Presence] in Serum

2.87

1.86

3.9

3.8

—

(3045142) Bone marrow Pathology biopsy report

1.99

1.85

1.5

1.3

—

(21494755) Public health laboratory ask at order entry panel

145

1770

0.80

1.82

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

453

1.41

1.82

1.4

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

211

1788

1.21

1.79

1.4

titre

484.7

579.2

0.29

356

(40760892) CBC W Ordered Manual Differential panel - Blood

327

2883

1.18

1.78

4.8

4.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

224

1.58

1.77

1.4

u/ml

102.5

106.1

0.08

(3037756) Immunofixation for Serum or Plasma

124

1.79

1.76

2.7

1.6

—

(3019150) Specific gravity of Urine by Refractometry

279

2431

1.18

1.75

4.1

3.4

kg/l

1.0

0.02

320

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.23

1.74

1.2

1.1

—

(3045414) Leukocytes [Presence] in Urine

500

1.38

1.74

1.6

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

171

1.65

1.71

5.5

3.5

mg/l

33.2

78.8

0.70

146

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

177

0.45

1.70

1.4

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

338

2999

1.17

1.70

4.1

3.5

estimate

0.0

1.34

139

1072

(3025468) Yersinia sp identified in Specimen by Organism specific culture

126

1.76

1.68

2.0

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

104

1.84

1.67

2.1

2.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

127

1.74

1.64

2.0

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

127

1.74

1.64

2.0

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

127

1032

1.25

1.61

4.0

3.8

24.4

21.0

1.24

422

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

1.92

1.60

1.2

u/l

56.3

54.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.51

1.60

1.5

2.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.70

1.58

1.0

—

(3017732) Neutrophils [#/volume] in Blood

106

845

1.28

1.58

3.0

2.4

e9/l

3.6

4.1

1.75

712

(3024522) Salmonella sp identified in Specimen by Organism specific culture

129

1.72

1.57

2.0

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

783

1.28

1.57

1.1

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

527

0.67

1.55

1.3

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

254

2219

1.18

1.55

1.3

u/ml

4.9

10.5

1.19

924

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.93

1.54

1.6

2.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

130

1.70

1.53

2.0

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

100

1.81

1.53

1.1

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

241

1.51

1.53

1.7

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

759

1.28

1.53

3.0

2.6

ug/l

0.6

0.7

0.58

454

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

218

1.53

1.49

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

155

1.62

1.47

3.1

2.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

285

1.45

1.46

1.7

2.0

g/l

1.4

0.03

245

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

171

1.59

1.46

5.6

3.5

mg/l

24.5

27.1

0.20

145

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

1.93

1.44

1.9

1.5

26.0

34.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.73

1.43

1.2

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

510

1.33

1.42

1.3

u/ml

0.2

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

797

1.26

1.39

1.1

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

108

880

1.25

1.37

15.3

14.5

inr

1.4

1.2

0.53

156

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.62

1.37

1.0

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

1.34

0.0

2.4

—

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

1165

11346

1.17

1.34

17.7

11.3

39.9

0.13

898

9270

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

128

1.65

1.33

2.0

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

412

1.35

1.31

1.0

1.1

u/ml

8.5

4.7

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.78

1.28

1.2

1.9

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.78

1.28

4.0

2.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.78

1.28

8.0

5.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.94

1.28

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

117

1400

0.82

1.26

1.4

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.83

1.25

1.0

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1.83

1.25

1.4

1.8

32.0

32.1

0.02

(4024509)

1.83

1.25

1.6

1.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

245

1.44

1.24

5.0

4.0

mmol/l

1.1

1.4

1.95

240

(3050129) First trimester maternal screen panel - Serum or Plasma

907

0.78

1.24

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

169

1951

0.85

1.23

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

237

1.45

1.23

1.7

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.77

1.23

1.0

1.1

—

(3011648) Oxygen content in Venous blood

1.91

1.23

1.9

2.1

10.9

11.7

0.30

(3020876) Protein [Mass/time] in 24 hour Urine

1.91

1.23

2.0

2.2

—

1.3

—

(21494434) Karyotype in Bone marrow

1.97

1.22

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.64

1.21

1.0

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

164

1.53

1.20

1.2

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

335

0.65

1.20

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

1.84

1.19

1.7

2.3

10.7

11.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

222

1.45

1.19

3.0

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.75

1.19

1.5

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

2.01

1.16

1.7

1.6

nmol/l

1.1

1.4

—

(3028433) Virus identified in Specimen by Culture

2.06

1.15

1.5

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.51

1.15

2.8

4.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

224

1.44

1.15

2.8

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

108

900

1.22

1.14

1.3

u/ml

130.7

217.2

1.29

835

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.85

1.13

1.6

2.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

629

0.75

1.13

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

167

1.51

1.12

2.1

g/l

136.2

133.1

0.20

122

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.01

1.12

5.3

3.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.39

1.09

1.4

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

283

2561

1.13

1.08

4.1

3.2

—

(3020650) Glucose [Presence] in Urine

2.19

1.08

1.1

1.7

—

(40768446) Kidney Pathology biopsy report

2.13

1.05

1.9

1.4

—

(4035726)

101

846

1.21

1.03

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.06

1.03

3.4

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.00

1.00

3.4

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.84

0.98

4.8

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.84

0.98

1.7

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.84

0.98

4.8

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.84

0.98

4.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.84

0.98

4.8

1.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

615

0.77

0.98

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

1.81

0.98

1.5

g/l

36.8

34.5

0.21

(3022493) Free Hemoglobin [Mass/volume] in Plasma

0.00

0.97

0.0

5.8

—

60.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.81

0.96

1.0

—

(3005033) Fetal Nuchal fold Thickness US

613

0.78

0.96

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

315

2891

1.12

0.95

1.8

1.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

208

1.40

0.95

3.6

3.9

57.9

57.0

0.20

208

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

688

0.79

0.94

1.5

—

(3047189) Immunofixation for 24 hour Urine

2.23

0.93

2.5

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

150

1.47

0.93

3.4

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.74

0.92

1.0

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

201

1.40

0.91

3.4

3.6

e9/l

4.3

4.1

0.28

201

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

123

1063

1.17

0.91

7.0

5.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.63

0.91

2.0

2.5

—

(3004616) Nuclear Ab [Presence] in Serum

151

1.46

0.90

1.5

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.07

0.89

1.3

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.91

0.88

1.0

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

103

1.56

0.87

1.9

1.6

51.6

56.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

229

1.36

0.87

1.9

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

252

0.67

0.86

1.4

1.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

660

1.21

0.86

1.3

miu/ml

224.0

229.8

0.04

352

(40760888) Immunoglobulin light chains.free panel - Serum

128

1.49

0.86

7.4

3.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

128

1.49

0.86

1.0

1.1

—

(4094501)

230

1.36

0.85

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

568

0.79

0.85

1.8

2.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

1.63

0.84

1.0

1.2

—

182.9

—

(3042631) Mycobacterium sp identified in Specimen

1.60

0.84

2.5

2.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

121

1.49

0.83

2.2

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

253

2314

1.11

0.82

1.4

1.3

iu/ml

26.9

25.6

0.08

729

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

276

1.31

0.81

1.4

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1.73

0.79

1.2

mmol/l

5.2

6.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1092

0.85

0.79

1.6

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

190

1.38

0.79

2.8

2.6

ug/min

48.6

140.3

1.36

127

(4146454)

1.67

0.78

2.7

2.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

1.63

0.78

7.8

2.8

63.9

54.9

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.52

0.78

2.0

1.4

g/l

0.9

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.77

0.76

1.0

1.1

—

80.9

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.77

0.76

1.0

1.1

—

69.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.52

0.75

1.5

1.3

—

(3044927) Protein electrophoresis panel - Urine

1.65

0.75

1.1

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

133

1.43

0.73

1.3

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.85

0.73

5.9

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.85

0.73

5.9

2.1

—

(4027681)

100

1.51

0.73

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.00

0.72

2.6

2.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.80

0.72

5.9

2.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.80

0.72

2.0

2.8

—

(3051651) Icteric interference index of Serum or Plasma

1.61

0.72

2.3

3.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

1.55

0.72

1.1

1.5

umol/l

10.5

10.2

0.07

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

134

1.42

0.71

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.75

0.71

3.4

1.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.93

0.70

1.0

1.2

54.6

37.3

—

(1002224) Polysomnography panel

583

1.19

0.70

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

128

1437

0.88

0.70

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.53

0.69

2.4

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

363

3412

1.09

0.68

2.5

2.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.56

0.68

3.9

2.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.53

0.68

1.0

1.1

—

9.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

223

1.31

0.66

1.7

e6/l

8063.8

11500.6

0.37

169

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

111

1.45

0.66

1.3

1.2

u/ml

0.1

0.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.59

0.65

1.0

1.2

—

(3035880) pH of Pleural fluid

1.73

0.64

1.4

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.52

0.62

1.1

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.52

0.62

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

388

1.22

0.62

2.6

1.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

208

1.30

0.62

1.0

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.59

0.62

1.5

1.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.67

0.61

3.0

1.8

—

(3004451) EKG impression Narrative

1.67

0.61

1.4

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.60

0.61

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.48

0.60

1.2

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

1.50

0.60

2.1

3.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

388

0.79

0.59

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

219

1.28

0.58

1.6

1.2

u/ml

4.0

5.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

231

0.73

0.58

1.0

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.47

0.58

3.9

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.47

0.58

3.9

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.47

0.58

3.9

1.7

—

(3045424) Erythrocytes [Presence] in Urine

184

1.31

0.58

1.2

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.56

1.5

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

141

1.35

0.56

2.2

1.6

—

17.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

495

1.18

0.56

1.4

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

124

1.38

0.56

1.4

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.62

0.55

3.5

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.62

0.55

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

1.45

0.55

1.5

mmol/l

5.5

5.6

0.07

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

125

0.64

0.54

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.58

0.54

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

151

1.33

0.54

1.8

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.54

0.53

3.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

143

1.33

0.52

2.1

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.43

0.52

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.43

0.52

1.3

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

203

0.74

0.51

1.4

1.6

mmol/l

7.0

7.4

—

123

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

260

1.24

0.51

1.4

1.2

u/ml

189.6

249.3

0.79

165

(3008401) Mugwort IgE Ab [Units/volume] in Serum

315

1.21

0.51

1.1

u/ml

2.1

1.3

0.16

128

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

516

5356

0.94

0.50

4.2

3.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

804

0.88

0.48

1.4

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

612

0.86

0.47

1.6

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

120

1.34

0.46

2.1

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

356

1.19

0.46

1.4

1.3

u/ml

18.5

9.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.43

0.46

1.3

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

347

1.19

0.46

1.9

1.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.61

0.46

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

147

1.30

0.45

1.4

1.5

mmol/l

9.0

11.8

—

(44813793)

103

1.36

0.45

1.1

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

1.45

0.44

1.4

1.3

u/l

6.0

7.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

723

0.88

0.43

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.62

0.43

1.0

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.62

0.43

1.0

1.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.52

0.41

1.6

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

342

3273

1.06

0.40

1.7

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.40

0.0

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

195

1.23

0.40

4.6

3.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.47

0.40

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

411

0.85

0.40

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.40

0.0

2.3

—

0.9

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.40

0.0

1.3

—

2.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

334

1.17

0.40

1.1

u/ml

5.7

6.5

0.07

178

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

267

2539

1.06

0.39

2.6

2.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.43

0.39

1.6

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.43

0.39

1.8

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.39

0.38

1.6

1.4

ug/l

8.7

7.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.39

0.38

1.4

3.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.33

0.37

1.4

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

365

1.16

0.36

1.2

1.1

u/ml

0.4

1.3

1.47

138

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

985

9705

1.05

0.36

3.9

3.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

755

1.11

0.36

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

356

1.16

0.36

1.3

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

813

1.10

0.36

2.3

2.2

ml/min/173m2

81.0

76.7

0.52

297

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.32

0.35

4.2

1.8

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

1.32

0.35

1.5

1.2

—

45.2

—

(3038026) Centromere Ab [Units/volume] in Serum

1.32

0.35

1.5

1.2

—

79.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.40

0.35

1.0

—

(3037121) Protein [Mass/volume] in Urine

320

1.16

0.35

2.1

3.4

g/l

0.1

0.2

1.31

119

(3039162) Centromere protein B Ab [Units/volume] in Serum

163

1.23

0.34

1.4

1.3

—

24.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

109

1.29

0.33

4.0

1.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

247

1.18

0.33

1.0

u/ml

2.2

2.0

0.08

135

(3021788) Differential panel - Synovial fluid

164

1.22

0.32

2.0

1.6

—

(40768806) Pleura Pathology biopsy report

1.30

0.30

1.4

1.6

—

(3000492) Spirometry study

129

1211

1.07

0.30

1.4

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.25

0.29

1.3

1.2

u/l

181.9

421.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

355

1.13

0.28

1.3

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

1.25

0.28

2.5

1.4

—

(40761535) Cells panel - Urine sediment

750

1.08

0.27

4.5

3.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

738

0.92

0.26

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.27

0.26

1.2

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.70

0.26

3.6

6.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

737

0.92

0.26

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

169

1611

1.06

0.25

1.8

1.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

160

1.19

0.25

2.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

736

0.92

0.25

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

240

2312

1.05

0.24

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

734

0.92

0.24

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

218

1.15

0.23

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

306

0.88

0.23

1.6

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

1.28

0.23

1.6

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

362

1.11

0.22

1.3

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.21

0.0

1.5

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.21

0.0

6.7

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3014891) Appearance of Pleural fluid

0.00

0.21

0.0

1.7

—

(3051339) Copper [Moles/volume] in Blood

0.00

0.21

0.0

1.1

—

16.2

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.21

0.0

2.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

377

0.90

0.21

1.4

pmol/l

47.9

114.7

1.42

371

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

230

0.87

0.21

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.21

0.0

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.20

0.0

1.8

—

7.9

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

5.8

—

0.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

112

0.80

0.20

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

763

1.07

0.19

3.7

4.2

ug/l

4.4

32.7

1.47

588

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.18

0.19

1.0

1.1

—

(3008898) HLA-B27 [Presence]

627

1.07

0.19

1.1

—

(3012441) Differential panel - Pleural fluid

1.15

0.19

1.2

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.19

0.18

1.1

126.0

110.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

262

1.11

0.17

3.4

3.7

u/ml

68.4

1369.8

1.14

227

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.13

0.17

1.0

1.1

miu/ml

1148.0

1562.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

272

1.11

0.17

1.1

u/ml

0.8

5.0

2.68

(4034850)

361

0.91

0.17

12.5

7.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

129

1.16

0.17

1.5

1.1

—

(3022621) pH of Urine by Test strip

719

1.06

0.17

3.1

2.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.18

0.16

3.9

3.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.13

0.16

1.0

—

(1761868) Lipid panel - Serum or Plasma

477

4695

1.02

0.15

2.5

2.3

—

(40768441) Liver Pathology biopsy report

1.11

0.15

1.1

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1.18

0.14

1.1

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

314

1.08

0.14

1.1

u/ml

0.4

2.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

139

0.86

0.14

1.8

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

636

1.06

0.14

1.6

1.7

mg/l

4.2

4.6

0.09

428

(3034274) Bile acid [Moles/volume] in Serum --fasting

295

1.09

0.14

2.7

2.3

umol/l

5.3

4.4

0.50

218

(3047007) Chlamydophila sp Ab [Presence] in Serum

222

0.90

0.13

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

132

1.14

0.13

1.4

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.17

0.13

5.0

2.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

104

1.16

0.12

1.4

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

104

1.16

0.12

1.4

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

104

1.16

0.12

1.4

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

104

1.16

0.12

1.4

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

104

1.16

0.12

1.4

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

116

0.86

0.12

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

1.16

0.11

1.5

2.2

—

(3044941) Cell count panel - Synovial fluid

147

0.88

0.11

1.5

1.4

—

(44790048)

126

0.87

0.11

1.6

1.4

—

(44790047)

126

0.87

0.11

1.6

1.4

—

(44790049)

126

0.87

0.11

1.6

1.4

—

(44806118)

126

0.87

0.11

1.6

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

105

1.14

0.11

1.4

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

250

1.08

0.11

1.1

u/ml

5.4

5.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.14

0.10

1.6

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.11

0.09

1.0

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.15

0.09

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.14

0.09

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

233

1.07

0.09

1.1

u/ml

0.1

0.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

253

1.07

0.08

1.3

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

138

1411

0.98

0.08

1.9

1.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

371

1.05

0.08

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.78

0.08

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

1.14

0.08

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

317

3209

0.98

0.08

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.80

0.07

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.07

0.07

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.07

0.07

1.0

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

418

0.96

0.07

1.7

2.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

157

1.08

0.07

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

838

1.03

0.07

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.02

0.07

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate

0.87

0.06

1.3

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

173

0.92

0.06

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

109

1.10

0.06

1.2

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

719

0.97

0.06

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

393

0.97

0.04

1.9

1.6

iu/ml

0.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.10

0.04

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.09

0.03

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

102

1.08

0.03

1.1

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

289

0.97

0.02

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

289

0.97

0.02

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

341

1.03

0.02

1.9

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

497

0.99

0.01

1.4

1.7

—

(4281824)

126

0.95

0.00

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

174

1.03

0.00

3.0

2.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

176

1766

1.00

0.00

2.1

1.9

—

(40768793) Breast Pathology biopsy report

324

0.99

0.00

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

221

1.00

0.00

3.5

3.3

mg/l

17.1

22.9

0.78

139

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

243

0.99

0.00

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

101

1013

1.00

0.00

1.3

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

205

1.02

0.00

3.4

3.8

u/ml

15.2

25.5

1.67

200

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.00

0.00

3.0

3.2

mg/l

11.1

7.7

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

5.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.86

0.00

1.8

1.7

—

880710.0

—

(3001729) Color of Synovial fluid

0.00

0.0

1.3

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.9

—

4.4

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

1.5

—

2.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(4212803)

0.00

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.91

0.00

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.6

—

19.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.0

2.7

—

394.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.7

—

342.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

2.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.02

0.00

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.92

0.00

1.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPERPRO and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_HYPERPRO	1.537 [1.32, 1.79]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.271

During the follow-up period (1.1.1998 — 31.12.2019), 228 out of 5615 females with E4_HYPERPRO died.

Males

Parameter	HR [95% CI]	p-value
E4_HYPERPRO	1.183 [1.0, 1.41]	0.056
Birth year	0.986 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 183 out of 1157 males with E4_HYPERPRO died.

Mortality risk

Mortality risk for people of age

years, who have E4_HYPERPRO.

N-year risk	Females	Males
1	0.122%	0.213%
5	0.784%	1.263%
10	2.184%	3.222%
15	4.019%	6.2%
20	7.392%	10.984%

Relationships between endpoints

↥

Index endpoint: E4_HYPERPRO – Hyperprolactinaemia

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hyperprolactinaemia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints